Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
Open accessAbstract
Mutations in the microtubule-associated protein tau gene have been linked to neurofibrillary tangle (NFT) formation in several neurodegenerative diseases known as tauopathies; however, no tau mutations occur in Alzheimer's disease, although this disease is also characterized by NFT formation and cell death. Importantly, the mechanism of tau-mediated neuronal death remains elusive. Aged mice expressing nonmutant human tau in the absence of mouse tau (htau mice) developed NFTs and extensive cell death. The mechanism of neuron death was investigated in htau mice, and surprisingly, the presence of tau filaments did not correlate directly with death within individual cells, suggesting that cell death can occur independently of NFT formation. Our observations show that the mechanism of neurodegeneration involved reexpression of cell-cycle proteins and DNA synthesis, indicating that nonmutant tau pathology and neurodegeneration may be linked via abnormal, incomplete cell-cycle reentry.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neuronal loss appears to be independent of tangle formation in some transgenic mouse models.
“However, neuronal loss appears to be independent of tangle formation in some transgenic mouse models (12)(13)(14).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 4× · see citing works
“A number of studies have detected DNA fragmentation, a hallmark of apoptosis, in AD tissue sections using the terminal deoxynucleotide transferase mediated dUTP nick-end labeling (TUNEL) method (Gavrieli et al., 1992; Sgonc and Wick, 1994) to identify 3 -OH ends of broken DNA (Su et al.”
MethodInfluentialAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1× · see citing works
“However, no mutations have been found in the tau gene in AD, and the relationship between tau pathology, amyloid deposition, and neuronal degeneration is difficult to determine (Hardy and Higgins, 1992; Taylor et al., 2002).”
BackgroundHengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 7,295 · cited 2× · see citing works
“These pathways are classically grouped based on stereotyped changes in nuclear morphology (Kerr, 1972; Leist and Jaattela, 2001), principally with respect to chromatin condensation, and on the presence or absence of the classic cell executioners: the caspases (for review, see Hengartner, 2000).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1× · see citing works
“…life in specific brain regions, including the subventricular zone of the lateral ventricles and the subgranular zone of the dentate gyrus of the hippocampus (Eriksson et al., 1998; Gould et al., 1998), but it does not normally occur in most regions with large populations of postmitotic neurons.”
BackgroundAssociation of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1× · see citing works
“Mutations in the tau gene have been linked to NFT formation in a number of tauopathies in which no -amyloid deposits develop (Hutton et al., 1998; Spillantini et al., 1998; Poorkaj et al., 2001).”
BackgroundSelf-citationWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 1× · see citing works
“The optical fractionator (West et al., 1991) was used to obtain quantitative estimates of neuronal loss with age in the htau mice.”
MethodFour deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,585 · cited 2× · see citing works
“These pathways are classically grouped based on stereotyped changes in nuclear morphology (Kerr, 1972; Leist and Jaattela, 2001), principally with respect to chromatin condensation, and on the presence or absence of the classic cell executioners: the caspases (for review, see Hengartner, 2000).”
BackgroundMethodNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1× · see citing works
“Moreover, there is evidence to suggest that some neurons in AD brain may die without forming NFTs (Gomez-Isla et al., 1997).”
BackgroundMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · cited 1× · see citing works
“Mutations in the tau gene have been linked to NFT formation in a number of tauopathies in which no -amyloid deposits develop (Hutton et al., 1998; Spillantini et al., 1998; Poorkaj et al., 2001).”
BackgroundGould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395 · cited 2× · see citing works
“…life in specific brain regions, including the subventricular zone of the lateral ventricles and the subgranular zone of the dentate gyrus of the hippocampus (Eriksson et al., 1998; Gould et al., 1998), but it does not normally occur in most regions with large populations of postmitotic neurons.”
BackgroundToxic Proteins in Neurodegenerative Disease
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251 · cited 1× · see citing works
“However, no mutations have been found in the tau gene in AD, and the relationship between tau pathology, amyloid deposition, and neuronal degeneration is difficult to determine (Hardy and Higgins, 1992; Taylor et al., 2002).”
BackgroundGoedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 1× · see citing works
“Tau isoforms can be separated into two groups, either 3R or 4R, depending on the inclusion or exclusion of exon 10 (Goedert et al., 1988, 1989; Lee et al., 1988; Himmler, 1989).”
BackgroundProliferating cell nuclear antigen (PCNA): a dancer with many partners
Maga, G., & Hübscher, U. (2003) · Journal of Cell Science · doi:10.1242/jcs.00653 · Cited by 1,100 · cited 1× · see citing works
“PCNA is a cell-cycle regulatory molecule that appears to play a coordinating role in a number of interactions at the DNA replication fork but has also been shown to be involved in DNA repair (for review, see Maga and Hubscher, 2003).”
BackgroundGoedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037 · cited 1× · see citing works
“Tau isoforms can be separated into two groups, either 3R or 4R, depending on the inclusion or exclusion of exon 10 (Goedert et al., 1988, 1989; Lee et al., 1988; Himmler, 1989).”
BackgroundTauopathy in <i>Drosophila</i> : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939 · cited 1× · see citing works
“Neurodegeneration has been demonstrated to occur without NFT formation in a Drosophila model of tauopathy in which wild-type human tau is expressed (Wittmann et al., 2001), although the extent of neurodegeneration was much higher in flies expressing mutant (R406W) human tau.”
BackgroundSchlüter, C., Duchrow, M., Wohlenberg, C., Becker, M., Key, G., Flad, H. ‐., & Gerdes, J. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.3.513 · Cited by 766 · cited 2× · see citing works
“The amount of ki67 is normally tightly regulated (Scholzen and Gerdes, 2000), and, although its exact function in the cell cycle is not known, it has been determined to be essential for cell proliferation (Schluter et al., 1993) and is aberrantly expressed in AD (Nagy et al., 1997).”
BackgroundGreenberg, S. G., & Davies, P. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 732 · cited 1× · see citing works
“Ultracentrifugation and Sarkosyl extraction (30 min incubation in 1% Sarkosyl) was performed according to Greenberg and Davies (1990) to obtain insoluble fractions of tau from htau mice aged 15 months.”
MethodSelf-citationHyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722 · cited 11× · see citing works
“E) (Andorfer et al., 2003), whereas many neurons with tau aggregates displayed intact nuclei (Fig.”
BackgroundMethodInfluentialSelf-citationTau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683 · cited 1× · see citing works
“Alterations in the ratio of 3R and 4R isoforms, normally equal in humans, have been linked to a number of neurodegenerative diseases that develop NFTs (Spillantini and Goedert, 1998; Hutton, 2001; Poorkaj et al., 2001).”
BackgroundThe Primary Structure and Heterogeneity of Tau Protein from Mouse Brain
Lee, G. S., Cowan, N. J., & Kirschner, M. W. (1988) · Science · doi:10.1126/science.3122323 · Cited by 680 · cited 1× · see citing works
“Tau isoforms can be separated into two groups, either 3R or 4R, depending on the inclusion or exclusion of exon 10 (Goedert et al., 1988, 1989; Lee et al., 1988; Himmler, 1989).”
BackgroundGunawardena, S., Her, L.-S., Brusch, R. G., Laymon, R. A., Niesman, I. R., Gordesky-Gold, B., Sintasath, L., Bonini, N. M., & Goldstein, L. S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00594-4 · Cited by 648 · cited 2× · see citing works
“…could be related to a disruption of axonal transport, which has been shown to cause cell death in several animal models (Gunawardena and Goldstein, 2001; LaMonte et al., 2002; Gunawardena et al., 2003) and has been suggested as a potential cause of neurodegeneration in AD (Goldstein, 2003).”
BackgroundDNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D., & Herrup, K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 607 · cited 2× · see citing works
“DOI:10.1523/JNEUROSCI.4637-04.2005 Copyright © 2005 Society for Neuroscience 0270-6474/05/255446-09$15.00/0 regions in which cell death is extensive (Lew et al., 1995; Busser et al., 1998; Yang et al., 2001, 2003; Herrup and Arendt, 2002).”
BackgroundInfluentialImmunohistochemical evidence for apoptosis in Alzheimer's disease.
Su, J., Anderson, A., Cummings, B. J., & Cotman, C. (1994) · NeuroReport · doi:10.1097/00001756-199412000-00031 · Cited by 607 · cited 4× · see citing works
“However, of these studies, some groups have detected morphological changes consistent with apoptosis (Su et al., 1994; Cotman and Anderson, 1995), whereas other groups have not (Lassmann et al.”
BackgroundResultInfluentialIshihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81127-7 · Cited by 564 · cited 1× · see citing works
“Mice expressing a cDNA for the shortest 3R isoform of tau (Ishihara et al., 1999) also develop tau pathology at high age (2 years), although the pathology is not obviously accompanied by neurodegeneration.”
BackgroundTaxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells
Yvon, A.-M. C., Wadsworth, P., & Jordan, M. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.947 · Cited by 550 · cited 2× · see citing works
“, 2004) because overstabilization (Jordan et al., 1996; Yvon et al., 1999) and destabilization (Jordan et al.”
BackgroundEctopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543 · cited 3× · see citing works
“DOI:10.1523/JNEUROSCI.4637-04.2005 Copyright © 2005 Society for Neuroscience 0270-6474/05/255446-09$15.00/0 regions in which cell death is extensive (Lew et al., 1995; Busser et al., 1998; Yang et al., 2001, 2003; Herrup and Arendt, 2002).”
BackgroundInfluentialLaMonte, B. H., Wallace, K. E., Holloway, B. A., Shelly, S. S., Ascaño, J., Tokito, M. K., Winkle, T. V., Howland, D., & Holzbaur, E. L. F. (2002) · Neuron · doi:10.1016/s0896-6273(02)00696-7 · Cited by 540 · cited 2× · see citing works
“…could be related to a disruption of axonal transport, which has been shown to cause cell death in several animal models (Gunawardena and Goldstein, 2001; LaMonte et al., 2002; Gunawardena et al., 2003) and has been suggested as a potential cause of neurodegeneration in AD (Goldstein, 2003).”
BackgroundNeurotrophins are required for nerve growth during development
Tucker, K. L., Meyer, M., & Barde, Y. (2001) · Nature Neuroscience · doi:10.1038/82868 · Cited by 526 · cited 2× · see citing works
“, 2000), with tau knock-out (KO) mice that have a targeted disruption of exon one of tau (Tucker et al., 2001).”
BackgroundMonoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., & Lee, V. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390607 · Cited by 488 · cited 15× · see citing works
“1B) resembled reactivity of these antibodies to NFTs from human brain (Fig.”
BackgroundInfluentialJackson, G. R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C. A., Massachi, S., & Geschwind, D. H. (2002) · Neuron · doi:10.1016/s0896-6273(02)00706-7 · Cited by 488 · cited 1× · see citing works
“NFT-like formation and cell death from tau with no mutations has been shown in a Drosophila model combining overexpression of wild-type human tau with manipulation of GSK3 (glycogen synthase kinase-3 ) activation (Jackson et al., 2002).”
BackgroundNeuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483 · cited 3× · see citing works
“DOI:10.1523/JNEUROSCI.4637-04.2005 Copyright © 2005 Society for Neuroscience 0270-6474/05/255446-09$15.00/0 regions in which cell death is extensive (Lew et al., 1995; Busser et al., 1998; Yang et al., 2001, 2003; Herrup and Arendt, 2002).”
BackgroundInfluentialCell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Węgiel, J., Bobinski, M., Jellinger, K. A., & Wı́sniewski, H. M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 458 · cited 17× · see citing works
“Cells in htau brains show evidence of DNA fragmentation but no activation of caspases DNA fragmentation can be detected using the TUNEL method (Gavrieli et al., 1992; Sgonc and Wick, 1994) to label broken 3 -”
BackgroundResultInfluentialLinking cyclins to transcriptional control
Coqueret, O. (2002) · Gene · doi:10.1016/s0378-1119(02)01055-7 · Cited by 428 · cited 1× · see citing works
“Cyclin D1 is another cell-cycle regulating molecule that is involved in controlling the progression of the cell cycle through G1-phase to the boundary of the S-phase (for review, see Coqueret, 2002).”
BackgroundGunawardena, S., & Goldstein, L. S. B. (2001) · Neuron · doi:10.1016/s0896-6273(01)00496-2 · Cited by 428 · cited 2× · see citing works
“This axonal pathology could be related to a disruption of axonal transport, which has been shown to cause cell death in several animal models (Gunawardena and Goldstein, 2001; LaMonte et al., 2002; Gunawardena et al., 2003) and has been suggested as a potential cause of neurodegeneration in AD…”
BackgroundGoode, B., & Feinstein, S. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.5.769 · Cited by 399 · cited 2× · see citing works
“The 3R isoforms of tau have been shown to have a lower affinity for microtubules (Goode and Feinstein, 1994; Panda et al., 1995) and a differential ability to regulate microtubule dynamics (Panda et al.”
BackgroundA potential role for apoptosis in neurodegeneration and Alzheimer's disease
Cotman, C. W., & Anderson, A. J. (1995) · Molecular Neurobiology · doi:10.1007/bf02740836 · Cited by 374 · cited 17× · see citing works
“Cells in htau brains show evidence of DNA fragmentation but no activation of caspases DNA fragmentation can be detected using the TUNEL method (Gavrieli et al., 1992; Sgonc and Wick, 1994) to label broken 3 -”
BackgroundResultInfluentialSrivastava, R. K., Srivastava, A. R., Korsmeyer, S. J., Nesterova, M., Cho‐Chung, Y. S., & Longo, D. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3509 · Cited by 363 · cited 2× · see citing works
“Changes in microtubule behavior have been shown to activate programmed cell-death signals (Srivastava et al., 1998; Giannakakou et al., 2001; Ye et al., 2001) (for review, see Michaelis et al.”
BackgroundStructure of the bovine tau gene: alternatively spliced transcripts generate a protein family
Himmler, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1389-1396.1989 · Cited by 320 · cited 1×
“Tau isoforms can be separated into two groups, either 3R or 4R, depending on the inclusion or exclusion of exon 10 (Goedert et al., 1988, 1989; Lee et al., 1988; Himmler, 1989).”
BackgroundCell cycle markers in the hippocampus in Alzheimer's disease
Nagy, Z., Esiri, M. M., Cato, A.-M., & Smith, A. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050665 · Cited by 318 · cited 2× · see citing works
“The amount of ki67 is normally tightly regulated (Scholzen and Gerdes, 2000), and, although its exact function in the cell cycle is not known, it has been determined to be essential for cell proliferation (Schluter et al., 1993) and is aberrantly expressed in AD (Nagy et al., 1997).”
BackgroundDuff, K., Knight, H., Refolo, L. M., Sanders, S., Yu, X., Picciano, M., Malester, B., Hutton, M. L., Adamson, J., Goedert, M., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0279 · Cited by 311 · cited 4× · see citing works
“, 2003) by crossing mice that express a tau transgene derived from a human PAC, H1 haplotype, termed 8c mice (Duff et al., 2000), with tau knock-out (KO) mice that have a targeted disruption of exon one of tau (Tucker et al.”
BackgroundMethodInfluentialSelf-citationConformational change as one of the earliest alterations of tau in Alzheimer's disease
Weaver, C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00157-3 · Cited by 310 · cited 2× · see citing works
“, 1997a,b, 1999) that is specific to abnormal tau (Weaver et al., 2000); and (3) PHF1 (paired helical filament), specific for phosphorylation at serines 396/404 (Ps396/ 404), reacting with later-stage NFTs (Otvos et al.”
BackgroundSelf-citationPanda, D., Samuel, J. C., Massie, M., Feinstein, S. C., & Wilson, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633508100 · Cited by 280 · cited 2× · see citing works
“, 1995) and a differential ability to regulate microtubule dynamics (Panda et al., 2003; Bunker et al., 2004).”
BackgroundKuan, C.-Y., Schloemer, A. J., Lu, A., Burns, K. A., Weng, W.-L., Williams, M. T., Strauss, K. I., Vorhees, C. V., Flavell, R. A., Davis, R. J., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3883-04.2004 · Cited by 279 · cited 1× · see citing works
“Involvement of cell-cycle mechanisms in the neuronal death that follows hypoxia-ischemia has also been suggested in two recent papers (Kuan et al., 2004; Wen et al., 2004).”
ResultSchmitz, C., & Hof, P. R. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00066-1 · Cited by 272 · cited 1× · see citing works
“The coefficient of error was calculated according to Schmitz and Hof (2000).”
MethodSelf-citationJicha, G. A., Lane, E., Vincent, I. J., Ötvös, L., Hoffmann, R., & Davies, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052087.x · Cited by 264 · see citing works
Self-citationGiannakakou, P., Robey, R., Fojo, T., & Blagosklonny, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204487 · Cited by 260 · cited 2× · see citing works
“Changes in microtubule behavior have been shown to activate programmed cell-death signals (Srivastava et al., 1998; Giannakakou et al., 2001; Ye et al., 2001) (for review, see Michaelis et al.”
BackgroundApoptosis and Alzheimer's disease
Behl, C. (2000) · Journal of neural transmission · doi:10.1007/s007020070021 · Cited by 255 · cited 1× · see citing works
“Attempts to discriminate whether the mode of cell death in AD is necrotic or apoptotic have yielded mixed results, with fea- tures of each pathway having been detected via a variety of biochemical and histological approaches (for review, see Behl, 2000).”
ResultAlzheimer Disease: DMA Fragmentation Indicates Increased Neuronal Vulnerability, but not Apoptosis
Stadelmann, C., Brück, W., Bancher, C., Jellinger, K., & Lassmann, H. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199805000-00009 · Cited by 221 · cited 1× · see citing works
“Still other groups have found evidence in AD tissue, suggesting that the mode of cell death is necrotic (Lucassen et al., 1997; Stadelmann et al., 1998).”
BackgroundPanda, D., Goode, B. L., Feinstein, S. C., & Wilson, L. (1995) · Biochemistry · doi:10.1021/bi00035a017 · Cited by 185 · cited 2× · see citing works
“The 3R isoforms of tau have been shown to have a lower affinity for microtubules (Goode and Feinstein, 1994; Panda et al., 1995) and a differential ability to regulate microtubule dynamics (Panda et al.”
BackgroundRegional synaptic pathology in Alzheimer's disease
Honer, W. G., Dickson, D. W., Gleeson, J., & Davies, P. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90111-a · Cited by 179 · cited 2× · see citing works
“Membranes were additionally probed with an antibody to SNAP-25 [synaptosome-associated protein of 25 kDa (SP-14)] (Honer et al., 1992) diluted 1:20 in 5% milk/1 TBS.”
MethodSelf-citationFrequency of Tau Gene Mutations in Familial and Sporadic Cases of Non-Alzheimer Dementia
Poorkaj, P., Grossman, M., Steinbart, E., Payami, H., Sadovnick, A., Nochlin, D., Tabira, T., Trojanowski, J. Q., Borson, S., Galasko, D., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.383 · Cited by 171 · cited 15× · see citing works
“1B) resembled reactivity of these antibodies to NFTs from human brain (Fig.”
BackgroundInfluentialBunker, J. M., Wilson, L., Jordan, M. A., & Feinstein, S. C. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-01-0062 · Cited by 154 · cited 4× · see citing works
“, 1995) and a differential ability to regulate microtubule dynamics (Panda et al., 2003; Bunker et al., 2004).”
BackgroundInfluentialLucassen, P., Chung, W., Kamphorst, W., & Swaab, D. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00007 · Cited by 142 · cited 1× · see citing works
“Still other groups have found evidence in AD tissue, suggesting that the mode of cell death is necrotic (Lucassen et al., 1997; Stadelmann et al., 1998).”
BackgroundMethods for the detection of apoptosis.
Sgonc, R., & Wick, G. (1994) · International Archives of Allergy and Immunology · doi:10.1159/000236777 · Cited by 142 · cited 4×
“A number of studies have detected DNA fragmentation, a hallmark of apoptosis, in AD tissue sections using the terminal deoxynucleotide transferase mediated dUTP nick-end labeling (TUNEL) method (Gavrieli et al., 1992; Sgonc and Wick, 1994) to identify 3 -OH ends of broken DNA (Su et al.”
MethodInfluentialWen, Y., Yang, S., Liu, R., Brun-Zinkernagel, A. M., Koulen, P., & Simpkins, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311768200 · Cited by 141 · cited 1× · see citing works
“Involvement of cell-cycle mechanisms in the neuronal death that follows hypoxia-ischemia has also been suggested in two recent papers (Kuan et al., 2004; Wen et al., 2004).”
ResultNeuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging
Troncoso, J. C., Martin, L. J., Dal Forno, G., & Kawas, C. H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00028-0 · Cited by 138 · cited 17× · see citing works
“Cells in htau brains show evidence of DNA fragmentation but no activation of caspases DNA fragmentation can be detected using the TUNEL method (Gavrieli et al., 1992; Sgonc and Wick, 1994) to label broken 3 -”
BackgroundResultInfluentialKimura, T., Ono, T., Takamatsu, J., Yamamoto, H., Ikegami, K., Kondo, A., Hasegawa, M., Ihara, Y., Miyamoto, E., & Miyakawa, T. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106875 · Cited by 134 · cited 4× · see citing works
“Immunohistochemistry Abnormal phosphorylation and conformational changes on tau can be detected with monoclonal antibodies, including the following: (1) CP13, reactive with phosphorylation on serine 202 on tau in pretangles (Kimura et al., 1996) and later-stage NFTs (Augustinack et al.”
BackgroundInfluentialMissense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms
Hutton, M. L. (2001) · Neurology · doi:10.1212/wnl.56.suppl_4.s21 · Cited by 125 · cited 1× · see citing works
“Alterations in the ratio of 3R and 4R isoforms, normally equal in humans, have been linked to a number of neurodegenerative diseases that develop NFTs (Spillantini and Goedert, 1998; Hutton, 2001; Poorkaj et al., 2001).”
BackgroundRe-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease
Herrup, K., & Arendt, T. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4315 · Cited by 94 · cited 2× · see citing works
“DOI:10.1523/JNEUROSCI.4637-04.2005 Copyright © 2005 Society for Neuroscience 0270-6474/05/255446-09$15.00/0 regions in which cell death is extensive (Lew et al., 1995; Busser et al., 1998; Yang et al., 2001, 2003; Herrup and Arendt, 2002).”
BackgroundInfluentialEndl, E., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3 · Cited by 89 · see citing works
Alkalinization of Acrosome Measured by GFP as a pH Indicator and Its Relation to Sperm Capacitation
Nakanishi, T., Ikawa, M., Yamada, S., Toshimori, K., & Okabe, M. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0353 · Cited by 83 · cited 2× · see citing works
“Incubation and mounting were performed at pH 4.0 to quench enhanced green fluorescent protein fluorescence (Nakanishi et al., 2001).”
BackgroundMethodInfluentialDo Disorders of Movement Cause Movement Disorders and Dementia?
Goldstein, L. S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00630-5 · Cited by 79 · cited 1× · see citing works
“…could be related to a disruption of axonal transport, which has been shown to cause cell death in several animal models (Gunawardena and Goldstein, 2001; LaMonte et al., 2002; Gunawardena et al., 2003) and has been suggested as a potential cause of neurodegeneration in AD (Goldstein, 2003).”
BackgroundTau neurofibrillary pathology and microtubule stability
Michaelis, M., Dobrowsky, R., & Li, G. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:289 · Cited by 60 · cited 1× · see citing works
“Changes in microtubule behavior have been shown to activate programmed cell-death signals (Srivastava et al., 1998; Giannakakou et al., 2001; Ye et al., 2001) (for review, see Michaelis et al., 2002).”
BackgroundApoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice.
Zehr, C., Lewis, J., McGowan, E., Crook, J., Lin, W.-L., Godwin, K., Knight, J. A., Dickson, D., & Hutton, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.011 · Cited by 54 · cited 1× · see citing works
“Zehr et al. (2004) have reported evidence of apoptosis in oligodendrocytes of mutant human tau transgenics, and we cannot exclude the possibility that the TUNEL-positive cells detected in htau mice were glia rather than neurons.”
BackgroundShrinkage necrosis of adrenal cortical cells
Kerr, J. R. (1972) · Journal of Pathology · doi:10.1002/path.1711070309 · Cited by 54 · cited 1×
“These pathways are classically grouped based on stereotyped changes in nuclear morphology (Kerr, 1972; Leist and Jaattela, 2001), principally with respect to chromatin condensation, and on the presence or absence of the classic cell executioners: the caspases (for review, see Hengartner, 2000).”
BackgroundStructure, function, and regulation of neuronal Cdc2-like protein kinase
Lew, J., Qi, R. Z., Huang, Q.-Q., Paudel, H. K., Matsuura, I., Matsushita, M., Zhu, X., & Wang, J. H.-C. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00014-6 · Cited by 44 · cited 2× · see citing works
“DOI:10.1523/JNEUROSCI.4637-04.2005 Copyright © 2005 Society for Neuroscience 0270-6474/05/255446-09$15.00/0 regions in which cell death is extensive (Lew et al., 1995; Busser et al., 1998; Yang et al., 2001, 2003; Herrup and Arendt, 2002).”
BackgroundInfluentialAltered conformation of recombinant frontotemporal dementia-17 mutant tau proteins.
Jicha, G. A., Rockwood, J. M., Berenfeld, B., Hutton, M., & Davies, P. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00980-x · Cited by 44 · see citing works
Self-citationSustained Activation of p34 cdc2 Is Required for Noscapine-induced Apoptosis*
Ye, K., Zhou, J., Landen, J., Bradbury, E., & Joshi, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100550200 · Cited by 43 · cited 2×
“Changes in microtubule behavior have been shown to activate programmed cell-death signals (Srivastava et al., 1998; Giannakakou et al., 2001; Ye et al., 2001) (for review, see Michaelis et al.”
BackgroundPKA Phosphorylations on Tau: Developmental Studies in the Mouse
Andorfer, C. A., & Davies, P. (2000) · Developmental Neuroscience · doi:10.1159/000017454 · Cited by 34 · cited 2× · see citing works
“Immunoblotting Immunoblotting was performed as described previously (Andorfer and Davies, 2000).”
MethodSelf-citationHerrup, K., & Yang, Y. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02158-x · Cited by 22 · cited 2× · see citing works
“Such a cell-cycle-driven mechanism of neurodegeneration has been proposed to occur in AD and several other tauopathies (Herrup and Yang, 2001; Yang et al., 2001, 2003) (for review see, Vincent et al.”
Background- Self-citation
Flagged first, then by citations
2 of the 74 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Hof PR (2000) Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains. Amsterdam: Elsevier.
Cited by
Sorted by citations
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · see citing works
Recovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227 · see citing works
Tau in Alzheimer Disease and Related Tauopathies
Iqbal, K., Liu, F., Gong, C., & Grundke, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,122 · see citing works
“[84] showed that in human tau transgenic mice, while there was widespread neurodegeneration, the PHF-containing neurons, however, appeared “healthy” in terms of nuclear morphology, suggesting that the polymerization of hyperphosphorylated tau into fibrils was probably neuroprotective [84].”
BackgroundClassification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031 · see citing works
“In transgenic mice overexpressing normal human tau, there are also signs of re-entry: tau accumulation could thus be the cause of the re-entry rather than its consequence [12].”
BackgroundTau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965 · see citing works
“A recent study has shown that tangles continue to form in tau-expressing transgenic mice even after tau expression is switched off, suggesting that soluble, rather than aggregated, tau species are neurotoxic, a view supported by the apparent dissociation between the number of tangles and the extent of neuronal death i…”
ResultRamsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702 · see citing works
“Most recent studies of this model suggest the mechanism of tau-mediated neuronal death may involve the re-expression of cell-cycle proteins, indicating incomplete re-entry of the cell cycle (Andorfer et al., 2005).”
BackgroundRegulation of Tau Pathology by the Microglial Fractalkine Receptor
Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · see citing works
“, 2003) and neurodegeneration (Andorfer et al., 2005).”
Maphis, N., Xu, G., Kokiko-Cochran, O. N., Jiang, S., Cardona, A., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Brain · doi:10.1093/brain/awv081 · Cited by 595 · see citing works
“3C), suggest that deficiency of microglial CX3CR1 in hTauCx3cr1 / mice induces neurodegeneration, which occurs several months prior to significant neuronal loss demonstrated in the hTau mice (12 months versus 17 months of age) (Andorfer et al., 2005).”
BackgroundInfluentialTau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Clos, A. L., Jackson, G. R., & Kayed, R. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-39 · Cited by 633 · see citing works
“Cell death and synaptic lesions occur independently of formation of NFTs in h-tau mice expressing non-mutant human tau [13,14].”
BackgroundMechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628 · see citing works
“[11] showed that in human tau transgenic mice, while there was widespread neurodegeneration, the PHF-containing neurons, however, appeared ‘‘healthy’’ in terms of nuclear morphology, suggesting that the polymerization of hyperphosphorylated tau into fibrils was probably neuroprotective [11].”
Involvement of oxidative stress in Alzheimer disease
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611 · see citing works
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609 · see citing works
The Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600 · see citing works
Animal models of neurodegenerative diseases
Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0236-8 · Cited by 576 · see citing works
“Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.”
Lee, S., Varvel, N. H., Konerth, M. E., Xu, G., Cardona, A. E., Ransohoff, R. M., & Lamb, B. T. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100265 · Cited by 539 · see citing works
Wang, J., Xia, Y., Grundke, I., & Iqbal, K. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129031 · Cited by 530 · see citing works
“[140].”
Asuni, A. A., Boutajangout, A., Quartermain, D., & Sigurdsson, E. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2361-07.2007 · Cited by 506 · see citing works
“In that model as well as in the htau model, region-specific dissociation of neuronal loss and neurofibrillary pathology has been observed (Andorfer et al., 2005; Spires et al., 2006), which suggests toxic effects of early stage pathological tau conformers that cannot easily be detected, analogous to A oligomers.”
Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
Berger, Z., Roder, H. M., Hanna, A., Carlson, A. M., Rangachari, V., Yue, M., Wszołek, Z. K., Ashe, K. H., Knight, J. A., Dickson, D. W., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0587-07.2007 · Cited by 485 · see citing works
“Neuronal cell death also occurred independently of histologically observed tangles in mice that express all six isoforms of wild-type human tau (Andorfer et al., 2005).”
BackgroundSelf-citationIdentification of oligomers at early stages of tau aggregation in Alzheimer's disease
Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Sarmiento, J., Troncoso, J., Jackson, G. R., & Kayed, R. (2012) · The FASEB Journal · doi:10.1096/fj.11-199851 · Cited by 527 · see citing works
The role of tau in neurodegeneration
Gendron, T. F., & Petrucelli, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-13 · Cited by 478 · see citing works
“Likewise, many of the neurons that accumulate NFT in aged transgenic mice overexpressing normal htau seem "healthy" in terms of nuclear morphology, while a number of dying neurons do not appear to have a significant load of tau filaments [69].”
Alzheimer disease models and human neuropathology: similarities and differences
Duyckaerts, C., Potier, M., & Delatour, B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 459 · see citing works
“Cell death in htau mice does not seem to be directly caused by the NFTs but appears to be linked to reexpression of proteins involved in cell-cycle and DNA synthesis [7].”
BackgroundPractical considerations for choosing a mouse model of Alzheimer’s disease
Jankowsky, J. L., & Zheng, H. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0231-7 · Cited by 449 · see citing works
“Even the htau model overexpressing wild-type human MAPT was initially described with notable neuronal loss, albeit at much later ages (~17 months) [42], and may have since waned with successive generations of breeding (see “Neurofibrillary tangles” section for more detail).”
BackgroundMethodMAPT mutations, tauopathy, and mechanisms of neurodegeneration
Strang, K. H., Golde, T. E., & Giasson, B. I. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0197-x · Cited by 424 · see citing works
Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo
Fulga, T. A., Elson-Schwab, I., Khurana, V., Steinhilb, M. L., Spires, T. L., Hyman, B. T., & Feany, M. B. (2007) · Nature Cell Biology · doi:10.1038/ncb1528 · Cited by 452 · see citing works
“Similarly, although wild-type human tau can show substantial toxicity when expressed in transgenic mic”
BackgroundProbing the biology of Alzheimer’s disease in mice
Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413 · see citing works
Microtubule-associated protein tau in development, degeneration and protection of neurons
Wang, J., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 395 · see citing works
Spires, T. L., Orne, J. D., SantaCruz, K., Pitstick, R., Carlson, G. A., Ashe, K. H., & Hyman, B. T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050840 · Cited by 401 · see citing works
Wang, C., Ward, M. E., Chen, R., Liu, K., Tracy, T. E., Chen, X., Xie, M., Sohn, P. D., Ludwig, C., Meyer-Franke, A., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.08.019 · Cited by 400 · see citing works
“In Drosophila and mouse models, overexpression of wild- type human tau induces neurodegeneration (Wittmann et al., 2001), axonopathy (Spittaels et al., 1999), and extensive cell death (Andorfer et al., 2005) independently of tangle formation.”
BackgroundChanges in the structural complexity of the aged brain
Dickstein, D. L., Kabaso, D., Rocher, A. B., Luebke, J. I., Wearne, S. L., & Hof, P. R. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00289.x · Cited by 460 · see citing works
“These mice exhibit tau pathology in neurons of the neocortex and hippocampus in patterns similar to that occurring in NFTs of human brain and exhibited overt neuronal loss (Andorfer et al., 2003, 2005).”
Self-citationReimagining Alzheimer's Disease—An Age-Based Hypothesis
Herrup, K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4521-10.2010 · Cited by 386 · see citing works
“In support of this concept, transgenic mice carrying human tau mutations develop a late-onset neurodegenerative phenotype that includes neuronal loss (Andorfer et al., 2005; Ramsden et al., 2005).”
BackgroundTherapeutic approaches to Alzheimer's disease
Klafki, H., Staufenbiel, M., Kornhuber, J., & Wiltfang, J. (2006) · Brain · doi:10.1093/brain/awl280 · Cited by 359 · see citing works
“Characteristic neuropathological findings include selective neuronal and synaptic losses (Morrison and Hof, 1997), extracellular neuritic plaques containing the b-amyloid peptide (Glenner and Wong, 1984; Masters et al., 1985) and neurofibrillary tangles (NFTs) composed of hyperphosphorylated forms of the tau protein (…”
BackgroundInfluentialOxidative Stress Signaling in Alzheimers Disease
Su, B., Wang, X., Nunomura, A., Moreira, P., Lee, H.-G., Perry, G., Smith, M., & Zhu, X. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898451 · Cited by 344 · see citing works
“Given the fact that neurons with NFT can survive for decades, which is consistent with data in mouse model that NFTs are not involved in neuronal death [120,121], it is tempting to suggest that the formation of neurofibrillary pathology is a further neuronal adaptation to chronic oxidative stress [122].”
Tau pathophysiology in neurodegeneration: a tangled issue
Spires‐Jones, T. L., Stoothoff, W. H., de Calignon, A., Jones, P., & Hyman, B. T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.007 · Cited by 317 · see citing works
Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease
Patterson, K. R., Remmers, C. L., Fu, Y., Brooker, S. M., Kanaan, N. M., Vana, L., Ward, S., Reyes, J. F., Philibert, K., Glucksman, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237974 · Cited by 354 · see citing works
Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E., & Davies, P. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1065-09.2009 · Cited by 329 · see citing works
“…mice develop tau pathology in an age-dependent manner We confirmed by immunohistochemistry that all htau animals from the two age groups exhibited an age-dependent tau pathology with very similar features to those present in human AD cases, as previously reported (Andorfer et al., 2003, 2005).”
BackgroundResultInfluentialSelf-citationOxidative stress mediates tau-induced neurodegeneration in Drosophila
Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318 · see citing works
“Interestingly, hallmarks of both apoptotic and necrotic cell death have been recently identified in neurons from transgenic mice expressing nonmutant forms of human tau (53).”
BackgroundMouse models of Alzheimer's disease
Hall, A. M., & Roberson, E. D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.017 · Cited by 317 · see citing works
Alzheimer disease, the two-hit hypothesis: An update
Zhu, X., Lee, H., Perry, G. L., & Smith, M. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 292 · see citing works
Naini, S. M. A., & Soussi‐Yanicostas, N. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/151979 · Cited by 318 · see citing works
“These mice also develop neurodegeneration and age-dependent memory loss [72, 73].”
BackgroundBemiller, S. M., McCray, T. J., Allan, K., Formica, S. V., Xu, G., Wilson, G., Kokiko-Cochran, O. N., Crish, S. D., Lasagna-Reeves, C. A., Ransohoff, R. M., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0216-6 · Cited by 299 · see citing works
“beginning at approximately 6 months of age [25, 26].”
BackgroundTau phosphorylation and aggregation in Alzheimer's disease pathology
Ávila, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.067 · Cited by 283 · see citing works
“In mice, two approaches have been followed to mimic the AD [55] or FTDP17 (see for example [56,57]) tauopathies.”
BackgroundVingtdeux, V., Davies, P., Dickson, D. W., & Marambaud, P. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0759-x · Cited by 297 · see citing works
“CP13 is commonly used to detect tau pathology in both early (pre-tangles) and more advanced stages of NFT accumulation, whereas PHF1 is a marker for later stage tangles [1, 2].”
Self-citationMolecular Pathogenesis of the Tauopathies
Götz, J., Halliday, G., & Nisbet, R. M. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012936 · Cited by 276 · see citing works
Absalon, S., Kochanek, D. M., Raghavan, V., & Krichevsky, A. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1327-13.2013 · Cited by 290 · see citing works
“Accumulating evidence suggests that CCE in neurons may precede tau and amyloid pathology, and that there is a link between CCE and tau-hyperphosphorylation (Andorfer et al., 2005; Park et al., 2007; Jaworski et al., 2009).”
BackgroundRecent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274 · see citing works
“2009) and recent evidence that NFTs in experimental models do not directly correlate with neuron loss (Andorfer et al. 2005; SantaCruz et al. 2005) suggests that affected neurons may be able to withhold NFT formation for a long time before they degenerate.”
BackgroundInfluentialImmunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Boutajangout, A., Quartermain, D., & Sigurdsson, E. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-10.2010 · Cited by 272 · see citing works
“The htau model (Jackson Laboratories, stock #004808) (Andorfer et al., 2005) was crossed with a model that expresses the PS1 M146L human mutation (Duff et al., 1996).”
BackgroundMethodTau-based therapies in neurodegeneration: opportunities and challenges
Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272 · see citing works
TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model
Khurana, V., Lu, Y., Steinhilb, M. L., Oldham, S., Shulman, J. M., & Feany, M. B. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.042 · Cited by 266 · see citing works
“The issue of causality has previously been unresolved, although important studies have documented aberrant neuronal cell-cycle markers in human tauopathies and, more recently, in a mouse tauopathy model [36].”
Chen, X., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00659 · Cited by 291 · see citing works
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Cassidy, L., Fernandez, F., Johnson, J. B., Naiker, M., Owoola, A. G., & Broszczak, D. A. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102294 · Cited by 283 · see citing works
NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
Amadoro, G., Ciotti, M. T., Costanzi, M., Cestari, V., Calissano, P., & Canu, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511065103 · Cited by 243 · see citing works
Li, H.-L., Wang, H.-H., Liu, S.-J., Deng, Y.-Q., Zhang, Y.-J., Tian, Q., Wang, X.-C., Chen, X., Yang, Y., Zhang, J.-Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609303104 · Cited by 225 · see citing works
Tau oligomers and tau toxicity in neurodegenerative disease
Ward, S., Himmelstein, D. S., Lancia, J. K., & Binder, L. I. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120134 · Cited by 244 · see citing works
A decade of modeling Alzheimer's disease in transgenic mice
MCGOWAN, E., ERIKSEN, J., & HUTTON, M. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.03.007 · Cited by 287 · see citing works
Soluble forms of tau are toxic in Alzheimer's disease
Kopeikina, K., Hyman, B., & Spires-Jones, T. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0032-y · Cited by 232 · see citing works
“These and other data argue that synaptic deficits occur in an NFT-independent manner, again making the case that soluble tau serves as the toxic entity [51, 52, 56, 70, 92, 118].”
BackgroundLamin Dysfunction Mediates Neurodegeneration in Tauopathies
Frost, B., Bardai, F. H., & Feany, M. B. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.039 · Cited by 226 · see citing works
“Ectopic expression of cell-cycle markers in postmitotic neurons and their coincidence with tau pathology is a well-described feature of tauopathies [15, 16], and abnormal activation of the cell cycle in neurons can drive apoptosis in tau-transgenic Drosophila [6].”
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Corre, S. L., Klafki, H., Plesnila, N., Hübinger, G., Obermeier, A., Sahagún, H., Monse, B., Seneci, P., Lewis, J. M., Eriksen, J. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602913103 · Cited by 221 · see citing works
Lewis, J. M., & Dickson, D. W. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1507-z · Cited by 221 · see citing works
“As a step forward, we suggest that more work should be performed using the Htau model which lacks murine tau [4], but in which both 3R and 4R human tau are spliced and translated, albeit in a different ratio than observed in either humans or mice.”
Wang, Y. P., Biernat, J., Pickhardt, M., Mandelkow�, E., & Mandelkow�, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703676104 · Cited by 205 · see citing works
Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs
Rocher, A. B., Crimins, J. L., Amatrudo, J. M., Kinson, M. S., Todd-Brown, M. A., Lewis, J., & Luebke, J. I. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.029 · Cited by 187 · see citing works
“For example, in mice that overexpress wild-type human tau, extensive neuronal death occurred prior to substantial deposition of aggregated tau and NFTs, and neurons that appeared to be dying exhibited no ultrastructural evidence of fibrillar tau (Andorfer et al., 2005).”
Are tau aggregates toxic or protective in tauopathies?
Cowan, C. M., & Mudher, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00114 · Cited by 215 · see citing works
“showed that, while there was widespread neurodegeneration, the PHF-containing neurons appeared “healthy” in terms of nuclear morphology, suggesting that the polymerized protein was probably neuroprotective (105).”
BackgroundMa, Q., Zuo, X., Yang, F., Ubeda, O. J., Gant, D. J., Alaverdyan, M., Teng, E., Hu, S., Chen, P., Maiti, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393751 · Cited by 212 · see citing works
“Selective Suppression of Soluble Tau Dimers by Curcumin in Aged hTauMice—AlthoughhTaumice develop age-dependent NFTs with neuronal hyperphosphorylated Tau accumulation by 12 months of age (22, 27), progression of pathophysiology beyond 17 months of age, specifically in relation to synaptic dysfunction or the presence…”
BackgroundMethodPolymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity
Alonso, A. D. C., Li, B., Grundke-Iqbal, I., & Iqbal, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603214103 · Cited by 206 · see citing works
Zommer, N., Sergeant, N., Schraen-Maschke, S., Blum, D., & Buee, L. (2012) · Current Alzheimer Research · doi:10.2174/156720512800492503 · Cited by 193 · see citing works
“Finally, the Ser422 epitope has not been analyzed in other available models similar to THY-‐Tau22 such as the htau model [42] [43].”
Yang, Y., Varvel, N. H., Lamb, B. T., & Herrup, K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3707-05.2006 · Cited by 174 · see citing works
“In addition, recent studies in transgenic mice producing wild-type human tau but no endogenous mouse tau have documented the formation of neurofibrillary tangles and neuronal cell death associated with altered CCEs (Andorfer et al., 2005).”
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells
Su, B., Wang, X., Lee, H., Tabaton, M., Perry, G. L., Smith, M. A., & Zhu, X. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.010 · Cited by 178 · see citing works
Boekhoorn, K., Terwel, D., Biemans, B. A. M., Borghgraef, P., Wiegert, O., Ramakers, G. J. A., de Vos, K., Krugers, H. J., Tomiyama, T., Mori, H., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5425-05.2006 · Cited by 167 · see citing works
“…van Praag et al., 1999; Shors et al., 2002; Jin et al., 2004; Shors, 2004), particularly because disruption or overexpression of human protein tau affects the cell cycle, neuronal maturation, and axonal elongation (Takei et al., 2000; Dawson et al., 2001; Zhao et al., 2003; Andorfer et al., 2005).”
BackgroundTau isoform regulation is region‐ and cell‐specific in mouse brain
McMillan, P., Korvatska, E., Poorkaj, P., Evstafjeva, Z., Robinson, L., Greenup, L., Leverenz, J., Schellenberg, G. D., & D'Souza, I. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21867 · Cited by 179 · see citing works
“In this model, expression of the normal tau protein is driven by the MAPT promoter and regulatory sequences (Andorfer et al., 2003, 2005).”
BackgroundThe PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
Bhaskar, K., Miller, M., Chludzinski, A., Herrup, K., Zagorski, M., & Lamb, B. T. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-14 · Cited by 177 · see citing works
“Third, neuronal CCEs are observed in a variety of transgenic mouse models of AD [3, 8 ].”
BackgroundJohnson, A. (2018) · Springer Singapore · doi:10.1007/978-981-13-0508-5 · Cited by 175
“Like CELF1, hnRNP H regulates INSR splicing in the opposite direction compared to MBNL1/2 [97].”
Cell division in the CNS: Protective response or lethal event in post-mitotic neurons?
Yang, Y., & Herrup, K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.002 · Cited by 156 · see citing works
“[108] Andorfer C, Acker CM, Kress Y et al.”
BackgroundA Decade of Tau Transgenic Animal Models and Beyond
Götz, J., Deters, N. A., Doldissen, A., Bokhari, L., Ke, Y. D., Wiesner, A., Schönrock, N., & Ittner, L. M. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00051.x · Cited by 174 · see citing works
“Furthermore, evidence for a role of cell cycle-regulated genes in neurodegeneration has been obtained in mice transgenic for wild-type human tau (3) and in tau-expressing human neuroblastoma cells (Hoerndli et al, unpublished).”
BackgroundThe sour side of neurodegenerative disorders: the effects of protein glycation
Miranda, H. V., & Outeiro, T. F. (2009) · The Journal of Pathology · doi:10.1002/path.2682 · Cited by 168 · see citing works
“Over-expression of tau protein (a microtubule-associated protein), hyperphosphorylation and mutations are known to contribute to its aggregation [60–62].”
BackgroundProteostasis of tau. Tau overexpression results in its secretion via membrane vesicles
Simón, D., García‐García, E., Royo, F., Falcón‐Pérez, J. M., & Ávila, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.11.022 · Cited by 156 · see citing works
Castillo‐Carranza, D. L., Gerson, J. E., Sengupta, U., Guerrero‐Munoz, M. J., Lasagna‐Reeves, C. A., & Kayed, R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132477 · Cited by 180 · see citing works
“Additionally, in animal models, disease phenotypes are not associated with NFT levels [7–15], including in mice overexpressing human tau (Htau mice) [16, 17].”
The role of extracellular Tau in the spreading of neurofibrillary pathology
Medina, M., & Avila, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00113 · Cited by 161 · see citing works
“…et al., 2010), axonogenesis (DiTella et al., 1994; Klein et al., 2002; Belkadi and LoPresti, 2008), interactions with the plasma membrane (Brandt et al., 1995; Lee et al., 1998; Maas et al., 2000), signal transduction (Lee et al., 2004; Ittner et al., 2010) and cell cycle (Andorfer et al., 2005).”
BackgroundFactors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
Gamache, J., Benzow, K. A., Forster, C. L., Kemper, L. J., Hlynialuk, C. J. W., Furrow, E., Ashe, K. H., & Koob, M. D. (2019) · Nature Communications · doi:10.1038/s41467-019-10428-1 · Cited by 176 · see citing works
Tissue-nonspecific Alkaline Phosphatase Promotes the Neurotoxicity Effect of Extracellular Tau
Dı́az-Hernández, M., Gómez‐Ramos, A., Rubio, A., Gómez‐Villafuertes, R., Naranjo, J. R., Miras‐Portugal, M. T., & Ávila, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145003 · Cited by 155 · see citing works
Nilson, A. N., English, K. C., Gerson, J. E., Whittle, T. B., Crain, C. N., Xue, J. J., Sengupta, U., Castillo‐Carranza, D. L., Zhang, W., Gupta, P. K., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160912 · Cited by 170 · see citing works
“Inflammation and cell death occur prior to, or independently, from the formation of NFTs in AD and in transgenic mouse models [9, 12, 13, 15, 31].”
BackgroundWhy Pleiotropic Interventions are Needed for Alzheimer's Disease
Frautschy, S. A., & Cole, G. M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8137-1 · Cited by 147 · see citing works
“Our ongoing studies (unpublished) show that a cocktail containing both DHA and bioavailable curcumin can limit cognitive deficits and tau pathology in human tau mice beginning treatment at 14 months which is well after tau pathology and cognitive deficits had developed [190, 191].”
BackgroundKimura, T., Yamashita, S., Fukuda, T., Park, J., Murayama, M., Mizoroki, T., Yoshiike, Y., Sahara, N., & Takashima, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601917 · Cited by 144 · see citing works
“PHF1 immunoreactivity, however, differed between adult and aged mice.”
BackgroundInfluentialLysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo
Khurana, V., Elson‐Schwab, I., Fulga, T. A., Sharp, K. A., Loewen, C. A., Mulkearns-Hubert, E. E., Tyynelä, J., Scherzer, C. R., & Feany, M. Β. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001026 · Cited by 148 · see citing works
“We have previously shown that tau-induced cell cycle reentry mediates neuronal apoptosis in the fly tauopathy model [18], a result that has been corroborated in rodent models model of tauopathy [23,24].”
Lee, H., Casadesús, G., Zhu, X., Castellani, R. J., McShea, A., Perry, G. L., Petersen, R. B., Bajić, V., & Smith, M. A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.013 · Cited by 132 · see citing works
“Interestingly, a recent transgenic mice study demonstrated that the overexpression of normal human tau protein induces neuronal apoptosis and cell cycle re-entry (Andorfer et al., 2005).”
BackgroundInfluentialSpilsbury, A., Miwa, S., Attems, J., & Saretzki, G. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2925-14.2015 · Cited by 140 · see citing works
Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
Maphis, N., Jiang, S., Xu, G., Kokiko-Cochran, O. N., Roy, S. M., Van Eldik, L. J., Watterson, D. M., Lamb, B. T., & Bhaskar, K. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0221-y · Cited by 144 · see citing works
“Notably, original reports on hTau mice suggested formation of mature tangles and neurodegeneration by 20 months of age [45, 62, 63].”
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
d’Abramo, C., Acker, C. M., Jimenez, H. T., & Davies, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062402 · Cited by 144 · see citing works
Self-citationTarget Identification for CNS Diseases by Transcriptional Profiling
Altar, C. A., Vawter, M. P., & Ginsberg, S. D. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.172 · Cited by 139 · see citing works
“…tangles: Histopathological and biochemical studies show that hippocampal CA1 pyramidal neurons of the AD brain bear intracellular NFTs, which have been modeled in mice that overexpress the human t protein (Ginsberg et al, 1999b; Trojanowski and Lee, 2005; Gotz, 2001; Andorfer et al, 2005).”
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
Kester, M. I., van der Vlies, A. E., Blankenstein, M. A., Pijnenburg, Y. A. L., van Elk, E. J., Scheltens, P., & van der Flier, W. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd8271 · Cited by 158 · see citing works
Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice
Ojo, J.-O., Mouzon, B., Greenberg, M. B., Bachmeier, C., Mullan, M., & Crawford, F. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182814cdf · Cited by 166 · see citing works
“This pathology is spatially distributed in relevant brain areas, such as the neocortex and hippocampus, with minimal brainstem and spinal cord involvement (30, 31).”
BackgroundSpires-Jones, T. L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H.-Y., Osetek, J. D., Jones, P. B., Bacskai, B. J., Feany, M. B., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3072-08.2008 · Cited by 137 · see citing works
The Basal Forebrain Cholinergic Projection System in Mice
Záborszky, L., van den Pol, A. N., & Gyengési, E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-369497-3.10028-7 · Cited by 167 · see citing works
“Aged mice expressing nonmutant human tau in the absence of mouse tau (Htau mice) developed NFTs and extensive cell death in the piriform cortex and hippocampus (Andorfer et al., 2005).”
BackgroundThe synapse as a treatment avenue for Alzheimer’s Disease
Peng, L., Bestard‐Lorigados, I., & Song, W. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01565-z · Cited by 158 · see citing works
“Tau directly induces synaptic loss and dysfunction Tau can have toxic effects on the synapse resulting in density loss and synaptic dysfunction independent from Aβ [32].”
BackgroundCdk5: Multitasking between physiological and pathological conditions
Lopes, J. P., & Agostinho, P. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.006 · Cited by 127 · see citing works
“Cell cycle re-entry has been observed in different neurodegenerative conditions, such as AD, PD, ALS or stroke (Ahn et al., 2008; Andorfer et al., 2005; Hoglinger et al., 2007; Lopes et al., 2009c; Neve and McPhie, 2006; Nguyen et al., 2003; Rashidian et al., 2005; Wen et al., 2005).”
Tau Aggregation and Toxicity in a Cell Culture Model of Tauopathy
Bandyopadhyay, B., Li, G., Yin, H., & Kuret, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700192200 · Cited by 133 · see citing works
Therapeutic strategies for tau mediated neurodegeneration
Yoshiyama, Y., Lee, V. M. ‐., & Trojanowski, J. Q. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303144 · Cited by 129 · see citing works
New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
Medina, M., & Ávila, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.013 · Cited by 118 · see citing works
“The first one uses the same 30mer peptide described above [102] in hTau/PS1 mice, which express all six wild-type isoforms of human tau on a mouse tau knockout background [34] plus human mutant (M146L) presenilin 1 (PS1) [105].”
Immunotherapy for Alzheimer‘s Disease: From Anti-β-Amyloid to Tau-Based Immunization Strategies
Panza, F., Frisardi, V., Solfrizzi, V., Imbimbo, B. P., Logroscino, G., Santamato, A., Greco, A., Seripa, D., & Pilotto, A. (2012) · Immunotherapy · doi:10.2217/imt.11.170 · Cited by 125 · see citing works
Tau as a Biomarker of Neurodegenerative Diseases
Schraen‐Maschke, S., Sergeant, N., Dhaenens, C., Bombois, S., Deramecourt, V., Caillet‐Boudin, M., Pasquier, F., Maurage, C., Sablonnière, B., Vanmechelen, E., et al. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.4.363 · Cited by 123 · see citing works
Tau‐targeted treatment strategies in Alzheimer's disease
Götz, J., Ittner, A., & Ittner, L. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01713.x · Cited by 127 · see citing works
“Similar results were obtained by immunizing mice that express all six human tau isoforms on an MAPT-/- background, the htau model (Andorfer et al., 2005), together with M146L mutant PS1 (Boutajangout et al.”
ResultLessons from Tau-Deficient Mice
Ke, Y. D., Suchowerska, A. K., van der Hoven, J., Silva, D. M. D., Wu, C. W., van Eersel, J., Ittner, A., & Ittner, L. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/873270 · Cited by 128 · see citing works
“These aged mice are further characterized by neuronal loss together with ventricle enlargement and reduced cortical thickness [56].”
Background
- Authors
- Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P.
- Affiliations
- Albert Einstein College of Medicine (US)
- Icahn School of Medicine at Mount Sinai (US)
- Nathan Kline Institute for Psychiatric Research (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-06-01
- Volume
- 25
- Issue
- 22
- Pages
- 5446-5454
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6725006
- OpenAlex
- W2016758992
- Cited by
- 511
- References
- 74
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 10 · 2023: 28 · 2022: 18 · 2021: 16 · 2020: 26 · 2019: 17 · 2018: 20 · 2017: 20 · 2016: 17 · 2015: 22 · 2014: 29 · 2013: 25 · 2012: 26
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (38623)
- National Institute on Aging (R37AG022102, AG022102, R01AG022102)
- National Institute of Mental Health (38623)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- tau protein, cell cycle re-entry, neuronal cell death, neurofibrillary tangles, tauopathy, Alzheimer's disease, transgenic mice, neurodegeneration, DNA synthesis, tau filaments
- MeSH terms
- Aging, Animals, Brain, Bromodeoxyuridine, Cell Cycle, Humans, Mice, Transgenic, Nerve Degeneration, Nerve Tissue Proteins, Neurons, Neurofibrillary Tangles, tau Proteins, Cell Death, Protein Isoforms, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review